Altshuler Shaham’s Zimmer Biomet ZBH Stock Holding History

Altshuler Shaham’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-245	Closed	-$26K	–	548
2022 Q2	$26K	Buy	+245	New	+$29.1K	﹤0.01%	366
2020 Q2	–	Sell	-111	Closed	-$11K	–	594
2020 Q1	$11K	Buy	111 +14	+14%	+$1.83K	﹤0.01%	291
2019 Q4	$14K	Buy	97 +27	+39%	+$3.73K	﹤0.01%	309
2019 Q3	$9K	Sell	70 -20	-22%	-$2.58K	﹤0.01%	309
2019 Q2	$10K	Buy	+90	New	+$10.5K	﹤0.01%	300

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Altshuler Shaham's ZBH Position: Q3 2022 in Review

Altshuler Shaham sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 245 shares — an estimated $26K sold.

Altshuler Shaham first reported a position in ZBH in Q2 2019 and held it in 5 quarters. The position peaked at $26K in Q2 2022. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Altshuler Shaham reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Altshuler Shaham sold 245 Zimmer Biomet shares in Q3 2022, an estimated $26K.
Altshuler Shaham first reported a position in Zimmer Biomet in Q2 2019 and held it in 5 quarters.
Altshuler Shaham's Zimmer Biomet position peaked at $26K in Q2 2022.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.